The Female Athlete's Heart: Facts and Fallacies. by Colombo, CSSS & Finocchiaro, G
Curr Treat Options Cardio Med (2018) 20: 101
DOI 10.1007/s11936-018-0699-7
Sports Cardiology (M Papadakis, Section Editor)
The Female Athlete’s Heart:
Facts and Fallacies
Clea Simone S. S. Colombo, MD1,2,*
Gherardo Finocchiaro, MD3
Address
*,1MSc Sports Cardiology, Cardiology Clinical Academic Group, St George’s Univer-
sity of London, Cranmer Terrace, SW 17 0RE, London, UK
Email: cleacolombo@gmail.com
2Cuore Dello Sport, Valinhos, R. Luiz Spiandorelli Neto, 60, s307. Valinhos, São
Paulo, Brazil
3Cardiology Clinical Academic Group, St George’s University of London, Cranmer
Terrace, SW 17 0RE, London, UK
Published online: 3 November 2018
* The Author(s) 2018
This article is part of the Topical Collection on Sports Cardiology
Keywords Female athletes I Cardiac remodeling I Sudden cardiac death
Abbreviations AF atrial fibrillation _ ARVC arrhythmogenic right ventricular cardiomyopathy _ CAC coronary artery
calcification _ CAD coronary artery disease _ CMR cardiac magnetic resonance _ DHT dihydrotestosterone _ HCM
hypertrophic cardiomyopathy _ LV left ventricular _ LVEDD left ventricular end diastolic diameter _ LVH left ventric-
ular hypertrophy _ LVM left ventricular mass _ LVWT left ventricular wall thickness _ RV right ventricle _ RWT relative
wall thickness _ SCD sudden cardiac death _ TWI T wave inversion
Abstract
Purpose of the review For many years, competitive sport has been dominated by men.
Recent times have witnessed a significant increase in women participating in elite sports.
As most studies investigated male athletes, with few reports on female counterparts, it is
crucial to have a better understanding on physiological cardiac adaptation to exercise in
female athletes, to distinguish normal phenotypes from potentially fatal cardiac diseases.
This review reports on cardiac adaptation to exercise in females.
Recent findings Recent studies show that electrical, structural, and functional cardiac
changes due to physiological adaptation to exercise differ in male and female athletes.
Women tend to exhibit eccentric hypertrophy, and while concentric hypertrophy or
concentric remodeling may be a normal finding in male athletes, it should be evaluated
carefully in female athletes as it may be a sign of pathology. Although few studies on
veteran female athletes are available, women seem to be affected by atrial fibrillation,
coronary atherosclerosis, and myocardial fibrosis less than male counterparts.
Summary Males and females exhibit many biological, anatomical, and hormonal
differences, and cardiac adaptation to exercise is no exception. The increasing participa-
tion of women in sports should stimulate the scientific community to develop large,
longitudinal studies aimed at a better understanding of cardiac adaptation to exercise in
female athletes.
Introduction
Regular intensive exercise leads to a series of electrical,
structural, and functional changes in the heart, col-
lectively named as the “athlete’s heart” [1]. Most of the
studies on cardiac adaptation to exercise have inves-
tigated male athletes. Until the first half of the twen-
tieth century, women were discouraged from practic-
ing sport at a competitive level because females were
thought to be physiologically unable to perform at
high standards, and it was believed that intense exer-
cise could lead to female infertility [2]. Women’s par-
ticipation in competitive sports has progressively in-
creased since the 1980s, and the proportion of females
among marathon runners has increased from 10% in
1980 to 43% in 2013 [3]. Females comprised almost
half of the athletes participating in the Olympic
Games in Rio de Janeiro in 2016 [4].
Although the recent years have witnessed an increas-
ing participation of women in competitive sport activi-
ties, data on cardiac adaptation in female athletes are
limited. Recent studies showed important gender differ-
ences in patterns of electrical and structural cardiac ad-
aptations [5•, 6••]. Incidence of sudden cardiac death
(SCD) in sports is significantly lower in female athletes
(male/female ratio is 10:1), and it is possible that
gender-related differences in cardiac adaptation to exer-
cise may offer some explanation [7].
The athlete’s heart
Regular intense exercise training promotes electrical, structural, and functional
cardiac changes which are influenced by age, sex, body size, ethnicity, and sport
discipline [8]. Physiological cardiac adaptation usually results in symmetrical
enlargement of all cardiac chambers and increased vagal tone, with typical ECG
changes as sinus bradycardia, AV blocks, and voltage criteria for right and left
ventricular hypertrophy. Early repolarization is commonly observed in athletes
and anterior T wave inversion (TWI) may be found, especially in individuals of
Afro-Caribbean descent. Cardiac remodeling may be marked in some athletes,
resulting to significant overlap with potentially fatal cardiac disease such as
cardiomyopathies [1].
Highly trained athletes exhibit an increase in left and right ventricular size
of 10–15% when compared with sedentary individuals. In Olympic athletes,
left ventricular (LV) size has been shown to be higher than the upper limits
of normal (LV end-diastolic diameter 9 54 mm) in almost half of the cases.
In some athletes, especially those engaged in high dynamic modalities, such
as rowing, cross-country, and cycling, the LV end-diastolic diameter may
exceed 60 mm [9]. The LV wall thickness may be mildly increased in white
athletes, but rarely exceeds 12 mm [10] whereas athletes of Afro-Caribbean
descent exhibit increased wall thickness (9 12 mm) in up to 18% of the cases
[11]. Although LV systolic function is usually within conventional normal
limits in athletes, endurance athletes may exhibit mildly reduced LV ejection
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fraction (G 50%) at rest, with significant contractility recruitment during
exercise [12, 13].
Similar to the LV, the right ventricle (RV) also enlarges in athletes. Zaidi et al.
showed that at echocardiography, 61% of male and 46% of female athletes
exhibit RV dimensions that fulfill the minor diagnostic criterion for arrhyth-
mogenic right ventricular cardiomyopathy (ARVC) [14].
Cardiac adaptation to exercise in female athletes
Although cardiac physiological adaptation may be qualitatively similar in
male and female athletes, on average women are smaller, have lower lean
body mass, and a different hormonal profile than men with significant
impact on cardiac dimensions [15]. In addition, sympathetic adrenergic
response during exercise as well as peak systolic blood pressure, stroke
volume, and peak VO2 during exercise may be lower in female athletes
[16, 17] . These differences may impact significantly on cardiac structural
changes resulting from intense training.
Electrocardiogram
Highly trained athletes often exhibit ECG patterns, which are reflective of
physiological adaptations to exercise and may in some cases overlap with
conditions predisposing to sudden cardiac death (SCD). The differential
diagnosis between physiology and pathology may be challenging, and
therefore, a good understanding of what constitutes a normal ECG in
specific athletic sub-groups is necessary. The recently published Interna-
tional recommendations for ECG interpretation in athletes provide a
thorough guidance for the interpretation of the athlete’s ECG, specifying
what type of ECG abnormalities would require further investigations to
rule out pathology [18•]. However, this document is predominantly based
on studies of male athletes. Recent studies show that sex has a significant
effect on ECG patterns in athletes. Finocchiaro et al. [6••] showed that
Sokolow-Lyon (SL) voltage criteria for left ventricular hypertrophy (LVH)
as well as left axis deviation are less common in female than in male elite
athletes in a study including more than 1000 highly trained athletes. The
SL criteria for LVH were present in 14% of females compared with 42% of
males, while left axis deviation was present in 0.4% of females compared
with 4% of males. Conversely, anterior T wave inversion (TWI) was more
prevalent in female athletes (9% in females vs 4% in males) [5•, 6••].
These findings were confirmed by the study by Malhotra et al. [5•], where
anterior TWI were found in 6.5% of female athletes and in 2.1% of male
athletes. The combination of J point elevation 9 0.1 mV in V1-V2 and
anterior TWI may be observed in male athletes, especially of Afro-
Caribbean origin, and this feature is regarded as a sign of physiological
adaptation to exercise [19]. However, this ECG sign is rarely observed in
highly trained female athletes, and its absence should not be considered as
suggestive of pathology [20] (Fig. 1).
Curr Treat Options Cardio Med (2018) 20: 101 Page 3 of 14 101
On the largest study on black female athletes, Rawlins et al. [21] showed that
female athletes of Afro-Caribbean descent exhibit more frequently anterior TWI
than white counterparts.
Echocardiogram
In male athletes, cardiac adaptation to exercise results in structural remodeling
of both ventricles and atria. As body size differs between males and females,
absolute cardiac dimensions are lower in females reflecting the different an-
thropometry [6••]. Scaling cardiac dimensions for body size is particularly
relevant in this context, in order to have a more accurate appreciation of the
degree of cardiac remodeling.
a
b
25 mm/s, 10 mm/mV
I aVR V1 V4
II aVL V2 V5
III aVF V3 V6
II
Fig. 1. ECG patterns in male (a) and female (b) athletes. Note the combination of anterior T wave inversion and significant (9
0.1 mV) J point elevation and the voltage criteria for LVH in the male athlete’s ECG. Conversely, the female athlete’s ECG is
characterized by the absence of J point elevation and voltage criteria for LVH.
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Left ventricle
On a large cohort (n = 600) of elite female athletes, Pelliccia et al. [22]
showed that an LV end-diastolic diameter (LVEDD) 9 54 mm, consistent
with a diagnosis of dilated cardiomyopathy (DCM), was present in 8%
of athletes. Maximal LV wall thickness was 14% greater in female
athletes in comparison with sedentary counterparts, but 23% lower than
male athletes. Importantly, none of the female athletes showed a LV
wall thickness 9 12 mm [22]. Therefore, an enlarged left ventricle raising
the suspicion of DCM or a wall thickness consistent with hypertrophic
cardiomyopathy (HCM) is less common in female athletes than male
counterparts. A female athlete showing an LV cavity exceeding 60 mm or
a LV wall thickness 9 12 mm should be further investigated to exclude
cardiac pathology. More recently, Finocchiaro et al. [6••] described the
effect of sex and sport discipline on LV geometry in 1083 white elite
athletes (41% female athletes). Absolute LVEDD 9 54 mm was observed
only in 7% of female athletes and LV wall thickness was ≤ 12 mm in all
females, confirming previous studies. Interestingly, LVEDD indexed for
BSA was higher in female athletes (LVEDD ≥ 31 mm/m2 in 18% of
females vs 10% of males). In the specific subgroup of athletes engaged
in dynamic exercise, females showed eccentric hypertrophy more fre-
quently than males, while males showed more commonly concentric
remodeling/hypertrophy. None of the female athletes demonstrated
RWT 9 0.48 or LVM 9 145 g/m2 [6••].
Rawlins et al. [21] compared 200 black female athletes with white
female athletes of similar age, size, and type of sport and demonstrated
that black female athletes exhibited a LV wall thickness 9 11 mm in 3% of
the cases compared with none of white female athletes. No female athlete
exhibited a LV wall thickness 9 13 mm [21]. These findings (Table 1 and
Fig. 2) suggest that cardiac adaptation to exercise tends to be characterized
by a more significant increase in chamber size rather than in wall thickness
in females. The presence of concentric hypertrophy or concentric remod-
eling in female athletes should be evaluated carefully and may be sugges-
tive of HCM in individuals with a family history of premature disease or
with an abnormal ECG.
Right ventricle
Exercise-induced cardiac remodeling is not a prerogative of the left heart
and the right heart is known to be very sensitive to volume loading
conditions, especially in endurance athletes. Zaidi et al. [14] showed that
although absolute RV dimensions are larger in male athletes compared
with females, RV size indexed for BSA is higher in female than male
athletes [23, 24]. This is particularly relevant as RV enlargement may
overlap with the pathological dilatation of the RV in patients with ARVC.
Athletic training has several deleterious effects in terms of risk of arrhyth-
mias and phenotype progression in patients with ARVC or even in carriers
of desmosomal mutations, and therefore, the differential diagnosis is
particularly relevant in athletes [25–27]. Echocardiographic evaluation of
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the RV should not rely on size alone, but also on other features such as the
presence of regional wall motion abnormalities or possible aneurysms in
order to distinguish RV alterations typical of ARVC from those detected in
athletes as a consequence of intensive physical activity [28, 29].
Atria
Left and right atrial enlargements are often observed in highly trained athletes.
In a recent meta-analysis of 54 studies, Iskandar et al. [30] confirmed that
athletes had greater LA size in comparison with controls with a 13% increase in
LA diameter and a 30% increase in LA volume index. Themean LA diameter was
36 mm in male elite athletes and 34 mm in female elite athletes, and the mean
diameter was 4.1 mm greater in comparison with sedentary controls [30]. Right
atrial remodeling is particularly evident in endurance athletes, as a response to
the prolonged increase in cardiac output [31–33]. Although most studies
included male athletes, in order to standardize right cardiac measurements,
Zaidi et al. [14] proposed an upper limit for RA area of 28 cm2 in male athletes
and 24 cm2 in female athletes. Interestingly, these authors found no significant
differences between black and whitemale athletes but greater RA dimensions in
white female athletes.
Table 1. Chamber dimensions at echocardiography in female athletes
Left ventricle
Pelliccia et al. 1996 Rawlins et al. 2010 Finocchiaro et al. 2016
Number ethnicity 600 females White 200 females Black 438 females White
LVWT 9 12 mm 0% 2% 0%
LVEDD 9 54 mm 8% 8% 7%
LVEDD index 29.8 ± 2.5 mm/m2 – 28.6 ± 2.7 mm/m2
LVM index 80 ± 16 g/m2 – 83 ± 17 g/m2
Left atrium
Pelliccia et al. 1996 Rawlins et al. 2010 Iskandar et al. 2015
Number ethnicity 600 females White 200 females Black 7018 athletes mixed
LA diameter 32.5 ± 3.5 mm 35.3 ± 4.7 mm 34.2 mm
LA volume index – – 30.9 ml/m2
Right ventricle and right atrium
D’Ascenzi et al. 2017 Zaidi et al. 2013 D’Ascenzi et al. 2017
Number ethnicity 363 females White 57 females Black 6806 athletes mixed
RVOTP 26.1 ± 3.6 mm 26.7 ± 3.8 mm 28 ± 2.0 mm
RVOT1 27.3 ± 4.1 mm 28.1 ± 4.5 mm 30 ± 1.0 mm
RVEDA 19.3 ± 3.9 cm2 21.6 ± 3.8 cm2 23 ± 0.1 cm2
RA area 14.8 ± 3.4 cm2 14.4 ± 3.1 cm2 16 ± 1.0 cm2
LA left atria, LVEDD left ventricular diastolic diameter, LVM left ventricular mass, LVWT left ventricular wall thickness, RA right atria, RVEDA right
ventricular end diastolic area, RVOT right ventricular outflow tract, RVOTP right ventricular outflow tract parasternal
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Determinants of cardiac adaptation to exercise in female
athletes
The determinants of sex differences in physiological cardiac adaptation to
exercise are not fully understood. However, hormonal, molecular, and genetic
mechanisms are thought to be involved.
Hormonal mechanisms
Testosterone and its metabolite dihydrotestosterone act directly on cardiac
myocytes stimulating myocardial hypertrophy [34, 35]. Conversely, estrogens
inhibit myocardial hypertrophy and the proliferation of cardiac fibroblasts. The
myocardial response to these hormones does not solely depend on the circu-
lating hormonal levels but also on their binding to cardiac receptors. Myocytes
contain androgenic and estrogenic receptors, which seem to modulate the
expression of specific cardiac genes with possible effects on sarcomeric proteins
[36, 37]. Moreover, estrogens increase nitric oxide level promoting peripheral
vasodilatation and afterload reduction, and estrogens and testosterone have
opposite effects on circulating levels of angiotensin converting enzyme activity
promoting, respectively, peripheral vasodilation and vasoconstriction with dif-
ferent effects on blood pressure [38–40].
Molecular mechanisms
Cardiac remodeling is modulated by multiple signaling pathways which in-
volve enzymatic regulation and cellular response. The energy substrate
VC for LVH and RVH
LAD
LVWT 
LVM
LVEDD
 CH/CR (endurance athletes)
LVWT
LVM
LVEDD/BSA
 EH (endurance athletes)
Anterior TWI
 risk of SCD  risk of SCD
 CAC  CAC
 CAD  CAD
 AF  AF
 Myocardial fibrosis  Myocardial fibrosis
Fig. 2. Main gender differences in cardiac adaptation to exercise. Abbreviations: AF: atrial fibrillation; BSA: body surface area; CAC:
coronary artery calcification; CAD: coronary artery disease; CH: concentric hypertrophy; CR: concentric remodeling; EH: eccentric
hypertrophy; LAD: left atrial dilation; LVEDD: left ventricular end diastolic diameter; LVH: left ventricular hypertrophy; LVM: left
ventricular mass; LVWT: left ventricular wall thickness; RVH: right ventricular hypertrophy; VC: voltage criteria.
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availability which depends on fatty acid oxidation and glucose uptake seems to
influence physiological cardiac hypertrophy. Some enzymes involved in this
process, as protein kinase B (AKT) and glycogen synthase kinase-3-beta (GSK
3), prevent the development of cardiac hypertrophy and their activity is re-
ported to be higher in females [41, 42]. Although these findings derive mainly
from experimental models, with lack of data in humans, they could explain, at
least in part, sex differences in cardiac remodeling.
Genetic mechanisms
A significant variability characterizes genes encoding for protein compo-
nents of the renin-angiotensin system [43]. Studies on athletes showed a
significant association between specific polymorphisms in the gene
encoding for angiotensin and degree of LVH induced by endurance train-
ing. Sex is supposed to have an important role on the prevalence and
expression of these polymorphisms possibly explaining the differences in
cardiac adaptation to exercise [44, 45].
Sudden cardiac death in female athletes
Sudden cardiac death (SCD) is ten-fold less common among competitive
female athletes in comparison with male counterparts [46, 47].
The commonest cause of SCD in older athletes (9 35 years) is atherosclerotic
coronary artery disease (CAD), whereas in young athletes (G 35 years), inherited
cardiac diseases, such as cardiomyopathies and channelopathies, predominate
[46]. Recent studies suggest that the most common finding at autopsy in young
athletes who died suddenly is a structurally normal heart (sudden arrhythmic
death syndrome or SADS), where primary arrhythmia syndromes as long QT
syndrome, Brugada syndrome, and cathecolaminergic polymorphic ventricular
tachycardia (CPVT) are the probable culprits [48, 49].
The higher prevalence of SCD in males was previously explained with
the higher proportion of male athletes participating in competitive
sports. However, the increasing participation of women in the recent
years was not paralleled with an increase of SCD incidence in female
athletes.
Various theories to explain the higher incidence of SCD in male
athletes have been proposed. Sympathetic tone and increased catechol-
amines may trigger malignant arrhythmias in individuals with pre-
existing cardiac disease and males appear to have a higher sympathetic
tone than females with possible deleterious effects in predisposed indi-
viduals [16, 50, 51].
Sex hormones affect the regulation of cardiac repolarization, with effects on
the QT interval with possible development of electrical instability and ar-
rhythmias [52, 53]. While androgens may have a role in the development of
LVH, estrogens may delay the phenotype expression in HCM, which may
manifest later in women [54–56], and although both HCM and ARVC are
transmitted as Mendelian autosomal dominant trait, their prevalence is higher
in males [28, 54]. The interplay between genetic and environmental factors in
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the development of cardiomyopathies, which are important causes of SCD
especially in young athletes, is complex and not completely understood.
Veteran female athletes
Regular exercise has several beneficial effects for human health, decreases
morbidity, and improves survival. Increasing numbers of athletes are able
to continue their athletic activities into middle and even old age, partic-
ipating at high-level athletic activity for many decades. Recent studies
postulated a deleterious effects of high-intensity long-term exercise, which
has been associated with greater prevalence of atrial fibrillation (AF),
ventricular arrhythmias, coronary artery calcification (CAC), and myocar-
dial fibrosis in veteran athletes [57, 58••]. Most of these studies investi-
gated the effects of long-term training in veteran male athletes, and to
date, few studies included female athletes.
Atrial fibrillation
A higher prevalence of atrial fibrillation (AF) in athletes compared with sed-
entary counterparts has been recently demonstrated [59]. A recentmeta-analysis
on the topic reported a prevalence of male athletes in studies where an associ-
ation between AF and sport was demonstrated [60].
The Women’s Health Study, which enrolled middle-age healthy wom-
en, showed that while a moderate amount of physical activity is associ-
ated with lower prevalence of AF, vigorous exercise regimens may increase
this risk of developing AF [61]. However, female athletes exhibit a less
pronounced atrial remodeling than male athletes, and larger atria are
more susceptible to micro re-entries favored by the increase in adrenergic
tone suggesting a possible lower risk of developing AF in women [62].
Although data on large cohort of male athletes suggest a 5-fold risk of
developing AF, studies on female athletes are on small samples, leaving
questions on the prevalence of AF in this specific group of individuals
still un-answered.
Coronary artery disease
A possible role of long-term strenuous exercise in the development of
coronary atherosclerosis has been recently shown in veteran athletes [63–
65]. A study comparing veteran endurance athletes with low atheroscle-
rotic risk profile and sedentary controls showed a higher prevalence of
significant coronary plaques and higher values of CAC in male athletes
[58••]. Female athletes constituted only 30% of the overall population,
and the prevalence of CAD or CAC score was similar in comparison with
female controls. A comparison between sedentary middle-age women and
women of similar age engaging in marathon running demonstrated a
lower prevalence of coronary plaques and less calcified plaques in ath-
letes, suggesting that the possible effects of long-term intense athletic
training on coronary atherosclerosis may be different in men and women
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[66•]. Further studies on larger cohorts are needed to clarify if female
veteran athletes are less likely to develop coronary atherosclerosis.
Myocardial fibrosis
Recent studies using cardiac magnetic resonance (CMR) showed a higher
prevalence of late gadolinium enhancement (LGE) in marathon and ultra-
marathon runners compared with age-matched veteran controls [67, 68]. A
correlation between the duration of training or number of marathons
completed and the presence of myocardial fibrosis was reported. It is
possible that repeated bouts of myocardial inflammation due to intense
exercise lead to a permanent damage, which may result in arrhythmias [69,
70]. The LGE pattern is usually non-ischemic indicating that myocardial
fibrosis is not related to CAD.
Again, most of the studies have included male athletes. A recent study
reported on male and female triathletes who were investigated with CMR
showing that LGE was present in 17% of males, but in none of the females
[71]. Interestingly, athletes showing LGE were characterized by higher
systolic blood pressure at peak exercise and increased LV mass index than
athletes without LGE at CMR, and the systolic blood pressure at peak
exercise was independently associated with myocardial fibrosis. It is pos-
sible that, as female athletes exhibit lower values of blood pressure at rest
and during exercise, they are less prone to develop myocardial fibrosis.
Myocardial fibrosis may constitute a substrate for potentially fatal ar-
rhythmias and SCD, and its lower prevalence in female athletes may
explain the lower incidence of SCD.
Conclusion and future perspectives
Long-term training results in a plethora of electrical, structural, and
functional cardiac changes. Patterns of electrical and structural remodel-
ing differ significantly between male and female athletes. While male
athletes tend to exhibit more frequently voltage criteria for LVH and
RVH at the ECG, in female athletes, anterior TWI is more common.
Absolute cardiac dimensions are higher in male athletes, and female
athletes rarely exhibit an enlarged LV raising the suspicion of DCM or LV
wall thickness consistent with HCM. Endurance female athletes appear to
adapt primarily by increasing ventricular dimensions as opposed to an
increase in LV wall thickness. Finally, female athletes are less prone to
sudden cardiac death and show less frequently coronary calcification,
atrial fibrillation, and myocardial fibrosis in comparison with male
counterparts.
Undoubtedly, males and females exhibit many biological, anatomical, and
hormonal differences, and cardiac adaptation to exercise is no exception. The
increasing participation of women in sports should stimulate the scientific
community to develop large and longitudinal studies aimed at a better under-
standing of cardiac adaptation to exercise in female athletes.
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What we know about…
ECG findings
– Anterior TWI is more common in female than male athletes.
– Voltage criteria for LVH and RVH are less frequent in female athletes.
Echocardiogram findings
– Female endurance athletes tend to develop eccentric hypertrophy.
– LVH 9 13 mm, RWT 9 0.48, or LVM 9 145 g/m2 in female athletes is
suggestive of pathology.
– RV enlargement is common in female athletes.
Clinical evolution
– Veteran female athletes show less coronary artery calcification than males.
– Female athletes are less prone to SCD than males.
What we believe…
– Sex hormones and genetic factors play a role in cardiac remodeling.
– A better understanding of the mechanisms involved in cardiac adaptation
to exercise in males and females may be useful to prevent SCD.
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